Invention Grant
- Patent Title: Cyanoisoquinoline compounds and methods of use thereof
- Patent Title (中): 氰基异喹啉化合物及其使用方法
-
Application No.: US14289573Application Date: 2014-05-28
-
Publication No.: US09174976B2Publication Date: 2015-11-03
- Inventor: Michael Arend , Lee A. Flippin , Min Wu , Eric D. Turtle , Wen-Bin Ho , Shaojiang Deng
- Applicant: FIBROGEN, INC.
- Applicant Address: US CA San Francisco
- Assignee: FIBROGEN, INC.
- Current Assignee: FIBROGEN, INC.
- Current Assignee Address: US CA San Francisco
- Agency: Sheppard Mullin Richter & Hampton LLP
- Main IPC: A61K31/47
- IPC: A61K31/47 ; A61K31/435 ; A61K31/44 ; C07D417/12 ; C07D217/26 ; C07D405/12 ; C07D413/12
Abstract:
The present invention relates to cyanoisoquinoline compounds suitable for use in treating hypoxia inducible factor-mediated and/or erythropoietin-associated conditions. The cyanoisoquinoline compounds of the invention have the following structure:
Public/Granted literature
- US20150031696A1 CYANOISOQUINOLINE COMPOUNDS AND METHODS OF USE THEREOF Public/Granted day:2015-01-29
Information query
